Harmony Biosciences Holdings, Inc. HRMY Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s return on equity?
- Harmony Biosciences Holdings, Inc. (HRMY) reported return on equity of 17.9% in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s return on equity changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s return on equity decreased by 27.7% year-over-year, from 24.7% to 17.9%.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s return on equity?
- Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s return on equity has grown at a -4.0% compound annual growth rate (CAGR), from 24.4% to 20.8%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.